PriceTargets.com logo

Colgate-Palmolive - CL Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $89.50
  • Forecasted Upside: -1.23%
  • Number of Analysts: 15
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 12 Buy Ratings
  • 0 Strong Buy Ratings
$90.61 As of 04/26/2024 01:33 PM ET
▲ +1.32 (1.48%)

This chart shows the closing price for CL by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Colgate-Palmolive Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CL and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CL

Analyst Price Target is $89.50
▼ -1.23% Downside Potential
This price target is based on 15 analysts offering 12 month price targets for Colgate-Palmolive in the last 3 months. The average price target is $89.50, with a high forecast of $100.00 and a low forecast of $76.00. The average price target represents a -1.23% upside from the last price of $90.61.

This chart shows the closing price for CL for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 15 polled investment analysts is to moderate buy stock in Colgate-Palmolive. This Moderate Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 12 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
11/3/2022
  • 0 strong buy ratings
  • 12 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
2/1/2023
  • 0 strong buy ratings
  • 12 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
5/2/2023
  • 0 strong buy ratings
  • 12 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
7/31/2023
  • 0 strong buy ratings
  • 12 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
10/29/2023
  • 0 strong buy ratings
  • 12 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
1/27/2024
  • 0 strong buy ratings
  • 12 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
3/27/2024
  • 0 strong buy ratings
  • 12 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
4/26/2024

Latest Recommendations

  • 0 strong buy ratings
  • 12 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/16/2024CitigroupBoost TargetBuy ➝ Buy$95.00 ➝ $100.00Low
4/12/2024BarclaysBoost TargetEqual Weight ➝ Equal Weight$82.00 ➝ $84.00Low
4/10/2024Stifel NicolausBoost TargetBuy ➝ Buy$89.00 ➝ $94.00Low
4/8/2024Evercore ISIBoost TargetOutperform ➝ Outperform$90.00 ➝ $96.00Low
3/1/2024The Goldman Sachs GroupInitiated CoverageBuy$93.00Low
1/29/2024Morgan StanleyBoost TargetOverweight ➝ Overweight$85.00 ➝ $93.00Low
1/29/2024UBS GroupBoost TargetBuy ➝ Buy$93.00 ➝ $95.00Low
1/29/2024Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$80.00 ➝ $88.00Low
1/29/2024Raymond JamesUpgradeMarket Perform ➝ Outperform$91.00Low
1/18/2024JPMorgan Chase & Co.Boost TargetOverweight ➝ Overweight$88.00 ➝ $90.00Low
1/16/2024BarclaysBoost TargetEqual Weight ➝ Equal Weight$75.00 ➝ $82.00Low
12/15/2023Bank of AmericaUpgradeNeutral ➝ Buy$90.00Low
11/29/2023JPMorgan Chase & Co.Boost TargetOverweight ➝ Overweight$83.00 ➝ $88.00Low
11/13/2023Jefferies Financial GroupInitiated CoverageBuy$87.00Low
10/30/2023Royal Bank of CanadaBoost TargetSector Perform ➝ Sector Perform$79.00 ➝ $80.00Low
10/30/2023Morgan StanleyLower TargetOverweight ➝ Overweight$89.00 ➝ $85.00Low
10/17/2023Bank of AmericaLower TargetNeutral ➝ Neutral$85.00 ➝ $75.00Low
10/16/2023Stifel NicolausUpgradeHold ➝ Buy$85.00 ➝ $81.00Low
10/12/2023JPMorgan Chase & Co.Lower TargetOverweight ➝ Overweight$85.00 ➝ $81.00Low
10/12/2023BarclaysLower TargetEqual Weight ➝ Equal Weight$81.00 ➝ $73.00Low
10/12/2023Sanford C. BernsteinLower Target$82.00 ➝ $76.00Low
10/11/2023CitigroupLower TargetBuy ➝ Buy$92.00 ➝ $85.00Low
9/22/2023HSBCInitiated CoverageBuy$84.00Low
8/1/2023BarclaysBoost TargetEqual Weight ➝ Equal Weight$77.00 ➝ $81.00Low
7/31/2023Royal Bank of CanadaReiterated RatingSector Perform ➝ Sector Perform$83.00Low
7/31/2023Deutsche Bank AktiengesellschaftBoost TargetBuy$88.00 ➝ $91.00Low
7/20/2023BarclaysLower Target$84.00 ➝ $77.00Low
5/1/2023Deutsche Bank AktiengesellschaftBoost Target$80.00 ➝ $88.00Low
5/1/2023Royal Bank of CanadaBoost Target$82.00 ➝ $83.00Low
5/1/2023Evercore ISIBoost Target$85.00 ➝ $91.00Low
5/1/2023Bank of AmericaBoost Target$80.00 ➝ $85.00Low
5/1/2023Wells Fargo & CompanyBoost Target$76.00 ➝ $81.00Low
5/1/2023CitigroupBoost Target$88.00 ➝ $92.00Low
3/29/2023UBS GroupBoost TargetBuy$84.00 ➝ $86.00Low
3/20/2023Deutsche Bank AktiengesellschaftLower Target$84.00 ➝ $80.00Low
2/16/2023CitigroupInitiated CoverageBuy$84.00Low
1/31/2023BarclaysLower TargetEqual Weight$80.00 ➝ $77.00Low
1/30/2023Wells Fargo & CompanyLower TargetEqual Weight$80.00 ➝ $76.00Low
1/30/2023Deutsche Bank AktiengesellschaftLower Target$87.00 ➝ $84.00Low
1/30/2023Morgan StanleyUpgradeEqual Weight ➝ Overweight$82.00Low
1/13/2023JPMorgan Chase & Co.Boost TargetOverweight$81.00 ➝ $86.00Low
1/3/2023Wells Fargo & CompanyBoost TargetEqual Weight$75.00 ➝ $80.00Low
12/6/2022Deutsche Bank AktiengesellschaftBoost TargetBuy$85.00 ➝ $87.00Low
11/21/2022Wolfe ResearchInitiated CoverageMarket PerformLow
11/1/2022BarclaysBoost TargetEqual Weight$72.00 ➝ $76.00Low
10/18/2022Credit Suisse GroupLower TargetOutperform$88.00 ➝ $85.00Low
10/17/2022Deutsche Bank AktiengesellschaftLower TargetBuy$87.00 ➝ $85.00Low
10/13/2022UBS GroupLower Target$90.00 ➝ $80.00Low
10/13/2022JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$79.00Low
10/10/2022The Goldman Sachs GroupLower TargetBuy$91.00 ➝ $81.00Low
10/3/2022Wells Fargo & CompanyLower TargetEqual Weight$80.00 ➝ $75.00Low
8/9/2022Wells Fargo & CompanyUpgradeEqual WeightN/A
8/2/2022BarclaysBoost TargetEqual Weight$71.00 ➝ $74.00Low
8/1/2022UBS GroupBoost TargetBuy$88.00 ➝ $90.00Low
8/1/2022Wells Fargo & CompanyUpgradeUnderweight ➝ Equal Weight$71.00 ➝ $80.00Low
7/22/2022UBS GroupBoost Target$88.00Low
7/21/2022JPMorgan Chase & Co.Lower Target$79.00 ➝ $78.00Low
7/19/2022Deutsche Bank AktiengesellschaftLower Target$88.00 ➝ $87.00Low
5/23/2022BarclaysLower TargetEqual Weight$77.00 ➝ $71.00Low
5/3/2022BarclaysLower Target$81.00 ➝ $77.00Low
5/3/2022Atlantic SecuritiesDowngradeOverweight ➝ Neutral$92.00 ➝ $80.00Low
5/2/2022Deutsche Bank AktiengesellschaftLower Target$91.00 ➝ $88.00High
4/13/2022Stifel NicolausLower Target$90.00 ➝ $88.00Low
4/13/2022Deutsche Bank AktiengesellschaftBoost TargetBuy$90.00 ➝ $91.00Low
4/7/2022Raymond JamesInitiated CoverageMarket PerformLow
4/1/2022BarclaysLower TargetEqual Weight$90.00 ➝ $81.00Low
3/30/2022JPMorgan Chase & Co.Lower TargetNeutral$86.00 ➝ $81.00Low
3/29/2022The Goldman Sachs GroupLower Target$104.00 ➝ $95.00Low
2/2/2022Sanford C. BernsteinUpgradeUnderperform ➝ Market Perform$77.00 ➝ $83.00Low
1/31/2022CitigroupBoost TargetNeutral$83.00 ➝ $86.00Low
1/31/2022Credit Suisse GroupLower TargetOutperform$95.00 ➝ $90.00Low
1/31/2022Deutsche Bank AktiengesellschaftLower TargetBuy$91.00 ➝ $90.00Low
1/31/2022Wells Fargo & CompanyLower TargetUnderweight$78.00 ➝ $76.00Low
1/31/2022Morgan StanleyBoost TargetEqual Weight$90.00 ➝ $91.00Low
12/16/2021Redburn PartnersInitiated CoverageNeutralHigh
12/16/2021UBS GroupInitiated CoverageNeutralHigh
11/2/2021BarclaysLower TargetEqual Weight$85.00 ➝ $83.00Low
11/2/2021Berenberg BankLower TargetHold$85.00 ➝ $77.00Low
11/1/2021Royal Bank of CanadaLower TargetSector Perform$90.00 ➝ $85.00Low
10/5/2021Bank of AmericaInitiated CoverageNeutralMedium
9/20/2021Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy$84.00 ➝ $86.00Low
8/2/2021Deutsche Bank AktiengesellschaftLower TargetHold$86.00 ➝ $84.00Low
6/23/2021UBS GroupInitiated CoverageBuy$95.00Low
6/20/2021Evercore ISIReiterated RatingBuy$95.00Low
6/9/2021Credit Suisse GroupUpgradeNeutral ➝ Outperform$80.00 ➝ $95.00High
5/3/2021Deutsche Bank AktiengesellschaftBoost TargetHold$84.00 ➝ $85.00Low
4/16/2021JPMorgan Chase & Co.Lower TargetNeutral$87.00 ➝ $85.00Low
2/1/2021Credit Suisse GroupUpgradeUnderperform ➝ Neutral$70.00 ➝ $80.00Low
1/28/2021Stifel NicolausDowngradeBuy ➝ Hold$83.00Medium
1/26/2021Berenberg BankUpgradeSell ➝ Hold$76.00Low
1/19/2021Sanford C. BernsteinInitiated CoverageUnderperform$77.00Low
1/4/2021Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform$90.00N/A
12/7/2020Wells Fargo & CompanyInitiated CoverageUnderweight$80.00Low
11/2/2020Royal Bank of CanadaBoost TargetOutperform$88.00 ➝ $90.00Low
11/2/2020UBS GroupBoost TargetBuy$85.00 ➝ $90.00Low
11/2/2020Morgan StanleyBoost TargetEqual Weight$80.00 ➝ $82.00Low
10/26/2020Truist FinancialBoost Target$80.00 ➝ $85.00Low
8/3/2020Deutsche Bank AktiengesellschaftBoost TargetHold$75.00 ➝ $78.00Low
8/3/2020Morgan StanleyBoost TargetEqual Weight$78.00 ➝ $80.00Low
7/30/2020Royal Bank of CanadaReiterated RatingBuy$88.00Low
7/27/2020Deutsche Bank AktiengesellschaftBoost TargetHold$73.00 ➝ $75.00Medium
7/22/2020Morgan StanleyDowngradeOverweight ➝ Equal Weight$78.00Medium
5/15/2020SunTrust BanksBoost TargetBuy$75.00 ➝ $80.00High
5/4/2020Credit Suisse GroupReiterated RatingSell$67.00Low
5/4/2020Stifel NicolausBoost TargetBuy$72.00 ➝ $75.00Medium
4/27/2020Morgan StanleyBoost TargetOverweight$72.00 ➝ $78.00Medium
3/31/2020Morgan StanleyInitiated CoverageOverweight$72.00Low
3/27/2020SunTrust BanksUpgradeHold ➝ Buy$75.00Medium
3/26/2020Stifel NicolausUpgradeHold ➝ Buy$80.00 ➝ $72.00Medium
3/22/2020Morgan StanleyUpgradeEqual Weight ➝ Overweight$76.00 ➝ $72.00High
3/20/2020Bank of AmericaUpgradeNeutral ➝ BuyHigh
2/4/2020Berenberg BankReiterated RatingSell$58.00Low
2/3/2020SunTrust BanksReiterated RatingHold$70.00Low
2/3/2020Morgan StanleyBoost TargetEqual Weight$71.00 ➝ $76.00Medium
2/3/2020CitigroupBoost TargetNeutral ➝ Neutral$71.00 ➝ $78.00Medium
2/3/2020Atlantic SecuritiesUpgradeNeutral ➝ OverweightLow
2/3/2020Royal Bank of CanadaUpgradeSector Perform ➝ Outperform$69.00 ➝ $91.00Low
1/27/2020Evercore ISIReiterated RatingBuy$80.00Low
12/19/2019Bank of AmericaDowngradeBuy ➝ Neutral$77.00 ➝ $74.00Low
12/12/2019Deutsche Bank AktiengesellschaftBoost TargetHold$72.00 ➝ $73.00Low
11/4/2019Morgan StanleySet TargetHold$74.00 ➝ $71.00Low
10/16/2019Berenberg BankInitiated CoverageSell$58.00Low
10/14/2019JPMorgan Chase & Co.Lower TargetNeutral$78.00 ➝ $76.00Medium
8/20/2019CitigroupBoost TargetNeutral$77.00 ➝ $79.00Low
8/13/2019Piper Sandler CompaniesInitiated CoverageOverweightMedium
7/29/2019Morgan StanleyBoost TargetEqual Weight$72.00 ➝ $74.00Low
7/29/2019Wells Fargo & CompanyBoost TargetMarket Perform$68.00 ➝ $70.00High
7/29/2019UBS GroupBoost TargetBuy$80.00 ➝ $82.00High
7/15/2019Morgan StanleyBoost TargetEqual Weight$68.00 ➝ $72.00Low
7/12/2019Wells Fargo & CompanyReiterated RatingHoldLow
7/12/2019Bank of AmericaSet TargetBuy$80.00Low
7/12/2019Deutsche Bank AktiengesellschaftBoost TargetHold$74.00 ➝ $76.00Low
6/17/2019Wells Fargo & CompanyReiterated RatingHold$65.00 ➝ $68.00Low
6/11/2019ArgusBoost TargetBuy$72.00 ➝ $82.00Low
4/29/2019MacquarieBoost TargetNeutral ➝ Neutral$65.00 ➝ $72.00Low
4/29/2019Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$62.00 ➝ $68.00Low
4/29/2019Jefferies Financial GroupBoost TargetHold ➝ In-Line$61.00 ➝ $73.00Low
4/29/2019JPMorgan Chase & Co.UpgradeUnderweight ➝ Neutral$62.00 ➝ $70.00Low
(Data available from 4/26/2019 forward)

News Sentiment Rating

1.05 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 32 very positive mentions
  • 18 positive mentions
  • 5 negative mentions
  • 1 very negative mentions
Mentions as of
9/29/2023
  • 20 very positive mentions
  • 11 positive mentions
  • 2 negative mentions
  • 3 very negative mentions
Mentions as of
10/29/2023
  • 10 very positive mentions
  • 11 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Mentions as of
11/28/2023
  • 27 very positive mentions
  • 18 positive mentions
  • 1 negative mentions
  • 3 very negative mentions
Mentions as of
12/28/2023
  • 34 very positive mentions
  • 14 positive mentions
  • 4 negative mentions
  • 1 very negative mentions
Mentions as of
1/27/2024
  • 38 very positive mentions
  • 22 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/26/2024
  • 35 very positive mentions
  • 18 positive mentions
  • 4 negative mentions
  • 0 very negative mentions
Mentions as of
3/27/2024
  • 32 very positive mentions
  • 18 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
4/26/2024

Current Sentiment

  • 32 very positive mentions
  • 18 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Colgate-Palmolive logo
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, and Soupline to a range of traditional and eCommerce retailers, wholesalers, and distributors. It includes pharmaceutical products for dentists and other oral health professionals. Its Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic pet products to help nutritionally support dogs and cats in different stages of health under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.
Read More

Today's Range

Now: $90.61
Low: $89.19
High: $92.25

50 Day Range

MA: $87.51
Low: $83.48
High: $90.05

52 Week Range

Now: $90.61
Low: $67.62
High: $92.25

Volume

4,291,269 shs

Average Volume

4,568,077 shs

Market Capitalization

$74.48 billion

P/E Ratio

32.59

Dividend Yield

2.25%

Beta

0.42

Frequently Asked Questions

What sell-side analysts currently cover shares of Colgate-Palmolive?

The following equities research analysts have issued stock ratings on Colgate-Palmolive in the last year: Bank of America Co., Barclays PLC, Citigroup Inc., Deutsche Bank Aktiengesellschaft, Evercore ISI, HSBC Holdings plc, Jefferies Financial Group Inc., JPMorgan Chase & Co., Morgan Stanley, Raymond James, Royal Bank of Canada, Sanford C. Bernstein, Stifel Nicolaus, StockNews.com, The Goldman Sachs Group, Inc., TheStreet, UBS Group AG, and Wells Fargo & Company.
View the latest analyst ratings for CL.

What is the current price target for Colgate-Palmolive?

16 Wall Street analysts have set twelve-month price targets for Colgate-Palmolive in the last year. Their average twelve-month price target is $89.50, suggesting a possible upside of 0.3%. Citigroup Inc. has the highest price target set, predicting CL will reach $100.00 in the next twelve months. Sanford C. Bernstein has the lowest price target set, forecasting a price of $76.00 for Colgate-Palmolive in the next year.
View the latest price targets for CL.

What is the current consensus analyst rating for Colgate-Palmolive?

Colgate-Palmolive currently has 3 hold ratings and 12 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for CL.

What other companies compete with Colgate-Palmolive?

Other companies that are similar to Colgate-Palmolive include Philip Morris International, Bruush Oral Care, The Hain Celestial Group, YanGuFang International Group and Reed's. Learn More about companies similar to Colgate-Palmolive.

How do I contact Colgate-Palmolive's investor relations team?

Colgate-Palmolive's physical mailing address is 300 PARK AVE, NEW YORK NY, 10022. The company's listed phone number is (212) 310-2000 and its investor relations email address is [email protected]. The official website for Colgate-Palmolive is www.colgatepalmolive.com. Learn More about contacing Colgate-Palmolive investor relations.